Hyperbaric oxygenation ameliorates indomethacin-induced enteropathy in rats by modulating TNF-α and IL-1β production

Digestive Diseases and Sciences

Volumn 51, Issue 8, 2006, Pages 1426-1433

  Yang, Z ^a   Nandi, J ^a   Wang, J ^a   Bosco, G ^a   Gregory, M ^a   Chung, C ^b   Xie, Y ^a   Yang, X ^a   Camporesi, E M ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SYRACUSE UNIVERSITY   (United States)

Author keywords

Hyperbaric oxygenation; IL 1 ; Inducible nitric oxide synthase; Intestinal ulceration; Myeloperoxidase; TNF

Indexed keywords

INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE MODEL; ENTEROPATHY; ENZYME ACTIVITY; HYPERBARIC OXYGEN; INJECTION; INTESTINE MUCOSA; INTESTINE ULCER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYPERBARIC OXYGENATION; INDOMETHACIN; INTERLEUKIN-1; INTESTINAL DISEASES; INTESTINAL MUCOSA; MALE; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; ULCER;

EID: 33748190278     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9088-2     Document Type: Article

References (41)

1. Podolsky DK (2002) Medical progress: inflammatory bowel disease. N Engl J Med 347:417-429
2. Akazawa A, Sakaida I, Higaki S, Kubo Y, Uchida K, Okita K (2002) Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosal of inflammatory bowel disease, particularly in patients with disease in the inactive phase. J Gastroenterol 37:345-353
3. Wardle TD, Turnberg LA (1994) Potential role for interleukin-1 in the pathophysiology of ulcerative colitis. Clin Sci 86:619-626
4. Wedrychowicz A, Stopyrowa J, Fyderek K, Miezynski W (2003) Stool interleukin 1β and interleukin 1 receptor antagonist concentration in children with active ulcerative colitis and during recovery. Eur J Pediatr 162:541-542
5. Martinez-Borra J, Lopez-Larrea C, Gonzalez S, Fuentes D, Dieguez A, Deschamps EM, Perez-Pariente JM, Lopez-Vazquez A, de Francisco R, Rodrigo L (2002) High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's. Am J Gastroenterol 97:2350-2356
6. Bertrand V, Guimbaud R, Tulliez M, Mauprivez C, Sogni P, Couturier D, Giroud JP, Chaussade S, Chauvelot-Moachon L (1998) Increase in tumor necrosis factor-alpha production linked to the toxicity of indomethacin for the rat small intestine. Br J Pharmacol 124:1385-1394
7. Bjarnasson I, Hayllar J, Mac Pherson AJ, Russel AS (1993) Side effects of nonsteroid antiinflammatory drugs on the small and large intestine in humans. Gastroenterology 104:1832-1847
8. Zhu F, Qian J, Pan G, Quan S (1998) The effect of interleukin-1 beta interleukin-8 in the pathogenesis of experimental colitis and evaluation of interleukin-1 receptor antagonist therapy. Acta Acad Med Sini 20:388-394
9. Shanahan F (2001) Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120:622-635
10. Lugering A, Schmidt M, Lugering N, Pauels HG, Domschke W, Kucharzik T (2001) Infliximab induces apoptosis in manocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 121:1145-1157
11. Tibbles PM, Edclsberg JS (1996) Hyperbaric oxygen therapy. N Engl J Med 334:1642-1648
12. Xu X, Yi H, Kato M, Suzuki H, Kobayashi S, Takahashi H, Nakashima I (1997) Differential sensitivities to hyperbaric oxygen of lymphocyte subpopulations or normal and autoimmune mice. Immunol Lett 59:79-84
13. Chen SY, Chen YC, Wang JK, Hsu HP, Ho PS, Chen YC, Sytwu HK (2003) Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmue (NZB X NZW) F1 mice. Clin Immunol 108:103-110
14. Brady CE3rd, Cooley BJ, Davis JC (1989) Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen. Gastroenterology 97:756-760
15. Nelson EW Jr, Bright DE, Villar LF (1990) Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management. Dig Dis Sci 35:1561-1565
16. Poliakova LV, Lukich VL, Grigor'eva GA (1991) Hyperbaric oxygenation and drug therapy in treatment of nonspecific ulcerative colitis and Crohn's disease. Fiziologicheskii Zhurnal 37:120-123
17. Karkumov M, Nikolov N, Georgiev L, Mitreva D, Uzunova A (1991) Hyperbaric oxygenation as a part of the treatment of chronic ulcerohemorrhagic colitis. Vutreshni Bolesti 30:78-80
18. Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S (1994) Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol 19:202-205
19. Colombel JF, Mathieu D, Bouault JM, Lesage X, Zavadil P, Quandalle P, Cortot A (1995) Hyperbaric oxygenation in severe perianal Crohn's diocese. Dis Colon Rectum 38:609-614
20. Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S, Pollack S (1997) Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol 17:154-159
21. Noyer CM, Brandt LJ (1999) Hyperbaric oxygen therapy for perineal Crohn's disease. Am J Gastroenterol 94:318-321
22. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J (2001) Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 33:337-339
23. Yang Z-J, Bosco G, Montante A, Ou XL, Camporesi EM (2001) Hyperbaric oxygen reduces intestinal ischemia reperfusion-induced TNF-a production and lung neutrophil sequestration. Eur J Appl Physiol 85:96-103
24. Benson RM, Minter LM, Osborne BA, Granowitz EV (2003) Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol 134:57-62
25. Saud B, Nandi J, Ong G, Finocchiaro S, Levine RA (2005) Inhibition of TNF-alpha improves indomethacin-induced entropathy in rats by modulating iNOS expression. Dig Dis Sci 50:1677-1683
26. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 38:1722-1734
27. Pedoto A, Nandi J, Oler A, Camporesi EM, Hakim TS, Levine RA (2001) Role of nitric oxide in acidosis-induced intestinal injury in anesthetized rats. J Lab Clin Med 138:270-176
28. Grisham MB, Benoit JN, Granger N (1990) Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 186:729-742
29. Reuter BK, Wallace JL (1999) Phosphodiesterase inhibitors prevent NSAID entropathy independently of effects on TNF-α release. Am J Physiol 277:G847-G854
30. Anthony A, Pounder RE, Dhillon AP, Wakefield AJ (2001) The inflammatory bowel disease study group. Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat. Aliment Pharmacol Ther 14:241-245
31. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB (1993) Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17:641-662
32. Rachmilewitz D, Karmeli F, Rubenstein I, Better OS (1998) Hyperbaric oxygen a novel modality to ameliorate experimental colitis. Gut 43:512-518
33. Veerabagu MP, Opara EI, Meguid MM, Nandi J, Olar A, Holtzapple PG, Levine RA (1996) Mode of food intake reduction in Lewis rats with indomethacin-induced ulcerative ileitis. Physiol Behav 60:381-387
34. Veerabagu MP, Meguid MM, Olar A, Levine RA (1996) Intravenous nucleosides and nucleotide promote healing of small bowel ulcers in experimental entrocolitis. Dig Dis Sci 41:1452-1457
35. Videla S, García-Lafuente A, Antolín M, Vilaseca J, Guarner F, Crespo E, Lez GG, Salas A, Malagelada JR (1998) Antitumor necrosis factor therapy in rat chronic granulomatous colitis: critical dose-timing effects on outcome. J Pharmacol Exper Ther 287:854-85
36. Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N (1995) Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha secretion from rat macrophages. Clin Exp Immunol 102:655-659
37. Inamoto Y, Okuno F, Saito K, Tanaka Y, Watanabe K, Morimoto I, Yamashita U, Eto S (1991) Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Commun 179:886-891
38. Saito K, Tanaka Y, Ota T, Eto S, Yamashita U (1991) Suppressive effect of hyperbaric oxygenation on immune responses of normal and autoimmune mice. Clin Exp Immunol 86:322-327
39. Tenenhaus M, Hansbrough JF, Zapata-Sirvent R, Neumann T (1994) Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition. Arch Surg 129:1338-1342
40. Gottlieb SF (1971) Effect of hyperbaric oxygen on microorganisms. Annu Rev Microbiol 25:111-152
41. Sebesteny M, Balogh A, Nemes A, Besznyak I (1976) Effect of hyperbaric oxygen on aerobic bacteria. Z Exp Chir 9:84-88